Skip to main content
Skip to content
Case File
sd-10-EFTA01392581Dept. of JusticeOther

EFTA Document EFTA01392581

GLOUS128 Patrick Gerschel GP-led transactions are a growing source of supply Secondary bespoke liquidity solutions are now part of the GP toolkit GP-led transactions now represent 20-25% of the secondary market GPs seeking Brand-name liquidity for worse managers performing funds or fund term extension Mid-market GPs looking to provide a Quality • liquidity option in mid-market year 10+ or managers • bespoke solution after a bump in the road Under- Zombies looking for perfor

Date
Unknown
Source
Dept. of Justice
Reference
sd-10-EFTA01392581
Pages
1
Persons
0
Integrity
Loading PDF viewer...

Summary

GLOUS128 Patrick Gerschel GP-led transactions are a growing source of supply Secondary bespoke liquidity solutions are now part of the GP toolkit GP-led transactions now represent 20-25% of the secondary market GPs seeking Brand-name liquidity for worse managers performing funds or fund term extension Mid-market GPs looking to provide a Quality • liquidity option in mid-market year 10+ or managers • bespoke solution after a bump in the road Under- Zombies looking for perfor

Ask AI About This Document

0Share
PostReddit

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
GLOUS128 Patrick Gerschel GP-led transactions are a growing source of supply Secondary bespoke liquidity solutions are now part of the GP toolkit GP-led transactions now represent 20-25% of the secondary market GPs seeking Brand-name liquidity for worse managers performing funds or fund term extension Mid-market GPs looking to provide a Quality • liquidity option in mid-market year 10+ or managers • bespoke solution after a bump in the road Under- Zombies looking for performing solutions make managers unlikely targets Illustrative transachons le He Partners DIAMOND CAIST1.! YE C:7 One EcpåIty Partners WARSUR6PIytaxc DNUANCED Lt^zir1/2.t.1 Can in!. DUKE STREET ilka:Yr-..• :Anna g• RAI] cny zit Sb GMT Zurmont Madison STAGE ZOMBIE GPs USSbn 15 14 13 12 11 10 9 8 7 6 5 4 3 a 2.4 2.7 1.9 2 1 0 18% CAGR 0.6 1.9 8.2 7.1 % of Secondary market deal volume 30% 14.0 9.0 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 GP-led secondaries - GP-led secondaries as % of total (I; Glendower Capital analysis based on Gieenhil Secondary Marker!' ends 3 Outlook. January 201 S; and Dow Jones Private Equity Anislyst Guide to the Secondary Market, June 20I Glendower Capital STRICTLY CONFIDENTIAL 25% 20% 15% 10% 5% 0% CONFIDENTIAL - PURSUANT TO FED. R. GRIM. P. 6(e) CONFIDENTIAL DB-SDNY-0097828 PROT1 PROT0

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.